Angel Desai
Division of Infectious Diseases
University of California, Davis

Angel Desai

Assistant Clinical Professor
UC Davis Health
Director, Global Health for Medical Students
Division of Infectious Diseases
University of California, Davis

“Spillovers 2.0: Assessing the Risk and Preparing for Disease X.

Angel Desai is an assistant professor in the Division of Infectious Diseases at UC Davis Health. Apart from her clinical responsibilities, her research focuses on using non-traditional epidemiological data for emerging diseases and outbreaks, particularly among displaced and other vulnerable populations. She is also interested in policy implications of communicable surveillance among refugees and IDPs, and global governance of public health systems for these populations.

She completed her internal medicine residency at the University of Washington in 2016 and infectious diseases fellowship at Massachusetts General Hospital in 2019 where she concurrently received a Master of Public Health from the Harvard T.H. Chan School of Public Health.

 

Christine Kreuder Johnson
School of Veterinary Medicine
University of California, Davis

Christine Kreuder Johnson

Christine Kreuder-Johnson

Professor, Medicine & Epidemiology
Director, EpiCenter for Disease Dynamics

Director, EpiCenter for Emerging Infectious Disease Intelligence, NIAID CREID Network
School of Veterinary Medicine
University of California, Davis

“On the Frontlines: Surveillance for Emerging Viruses”

Christine Kreuder Johnson is Professor of Epidemiology and Ecosystem Health and Director of the EpiCenter for Disease Dynamics. Her work is committed to transdisciplinary research to characterize impacts of environmental change on animal and human health, inform preparedness for emerging threats, and guide public policy at the intersection of emerging disease and environmental health.

Professor Johnson’s research has pioneered new approaches to characterization of emerging threats and disease dynamics at the animal-human interface in rapidly changing landscapes that constitute “fault lines” for disease emergence, disease spillover and subsequent spread. This work involves surveillance in wildlife and people with acute febrile illness in close contact with wildlife that are potential reservoirs for infectious disease. Her activities serve pressing research needs at the boundaries of science and policy, such as investigations into early indicators of unusual morbidity and mortality in wildlife, impacts of land use and climate change on disease in populations, and conservation and public health implications of harmful algal blooms and land-to-sea movement of pathogens in coastal systems.

To advance an understanding of environment and climate-related drivers for spillover and spread of ebolaviruses, coronaviruses, and arboviruses at the forest-urban ecosystem edge in Africa and Latin America, she leads the EpiCenter for Emerging Infectious Disease Intelligence, one of NIAID’s Centers for Emerging Infectious Disease (CREID). She also designed new approaches to animal and human surveillance in 30 resource-limited countries for USAID’s Emerging Pandemic Threats PREDICT program in partnership with public health, agricultural, and environmental government partners to inform on public health risk.

Her most rewarding professional experiences have been to support science-based decision making and public policy by providing epidemiologic support, congressional briefings, and invited testimony to state and federal governments and intergovernmental international partners. She was elected to the National Academy of Medicine (NAM) in 2021 and is an Honorary Fellow of the American Association for the Advancement of Science (AAAS). At UC Davis, she teaches One Health and ecosystem health and fosters a training program in applied research in wildlife epidemiology and disease ecology at the animal-human interface.

Stephanie Seifert
Paul G. Allen School for Global Health
Washington State University

Stephanie Seifert

Assistant Professor
Paul G. Allen School for Global Health
Washington State University

Lab website: Molecular Ecology of Zoonotic & Animal Pathogens Lab

“Title”

Steph completed her doctoral thesis research in the Ecology and Evolution of Infectious Disease Systems laboratory at UPenn. She then completed her postdoctoral training at the National Institutes of Health in the Laboratory of Virology/Virus Ecology Section where she studied the circulation of filoviruses and henipaviruses in African bats. This work included field sampling in the Republic of Congo and experimental work in the BSL4 at Rocky Mountain Laboratories. Steph has been active in outbreak response including EVD outbreaks in DRC and the COVID-19 pandemic. Steph received the NIH 2020 Merit Award for her participation in the early COVID-19 response including characterizing within-host evolution of SARS-CoV-2 in one of the first persistently infected patients. Steph is passionate about equity and accessibility in the sciences, particularly relating to international research collaborations. Outside the lab, Steph enjoys skiing with her partner, spending time with her three dogs, and riding horses.

 

Alison Kell
Molecular Genetics & Microbiology
University of New Mexico

Alison Kell
Assistant Professor
Molecular Genetics & Microbiology
University of New Mexico

Lab website: https://thekelllab.org/

“Understanding hantavirus virulence through host-specific innate immune activation”

Dr. Alison Kell completed her Bachelor’s degree in Ecology and Evolutionary Biology at the University of Colorado. She then made her way to the Pacific Northwest to complete her graduate work with Dr. Gael Kurath, developing novel in vivo superinfection assays to determine phenotypic and genetic correlates of viral fitness for the salmonid rhabdovirus, Infectious Hematopoietic Necrosis virus. To fully appreciate the impact of host immune pressure on viral fitness and evolution, she joined the laboratory of Dr. Michael Gale, Jr. at the University of Washington as a postdoctoral fellow. She is now excited to bring her independent research program to the University of New Mexico to study the molecular mechanisms underlying divergent host responses to orthohantavirus infection.

Asher Leeks
Yale School of Medicine
Yale University

Asher Leeks

Postdoctoral Fellow, Turner Lab
Yale School of Medicine
Yale University

“Social conflict within viral populations: from evolutionary causes to epidemiological consequences”

Dr. Asher Leeks studies social evolution in viruses. Viruses are intrinsically social organisms; every aspect of the viral lifecycle can be influenced by social interactions, from replication within a cell to transmission between hosts. He uses social evolution theory to understand how these interactions evolve and to predict their clinical consequences.

He is currently a JSMF postdoctoral fellow with Professor Paul Turner at Yale University. Previously, he studied at the University of Oxford with Professor Stuart West and Professor Ashleigh Griffin.

Simon Anthony
School of Veterinary Medicine
University of California, Davis

Simon Anthony

Associate Professor
Department of Pathology, Microbiology, & Immunology School of Veterinary Medicine
University of California, Davis

Lab website: https://anthonylab.vetmed.ucdavis.edu/

“Molecular evolution of SARS-CoV-2 and related bat coronaviruses”

Dr. Anthony’s research focuses on zoonotic and emerging infectious diseases, and specifically on the discovery, ecology, and evolution of viruses. He is interested in the factors that increase the risk of disease emergence in new hosts, including host or viral traits, and in the eco-evolutionary mechanisms that shape patterns of variation across scales.

 

Tyler Starr
Department of Biochemistry
University of Utah

Tyler Starr

Assistant Professor
Department of Biochemistry
University of Utah

Lab website: https://starr.biochem.utah.edu/

“Molecular evolution of SARS-CoV-2 and related bat coronaviruses”

We study molecular evolution at the host-virus interface, where specific protein-protein interactions drive rapid evolution of viral surface proteins, the host receptors that they bind, and the antibodies that inhibit these interactions. We leverage a combination of evolutionary, biochemical, and virological approaches to connect the functional effects of amino acid mutations to their biophysical origins and evolutionary consequences. Our basic studies of protein evolution shed light on important phenotypes in virology and immunity, from viral zoonosis to the development of broadly protective antibodies. We are building off current projects on SARS-CoV-2 and HIV to develop a broad research program studying diverse emerging viruses of public health interest.

Louise H. Moncla
School of Veterinary Medicine
University of Pennsylvania

Louise H. Moncla

Assistant Professor of Pathobiology
School of Veterinary Medicine
University of Pennsylvania

“Phylodynamic approaches for reconstructing highly pathogenic avian influenza evolution and transmission”

In the Moncla lab, we are interested in how viruses emerge in human populations, and transmit between them. We draw on tools from phylodynamics, virology, and population genetics to understand how viruses evolve within individuals, between populations, and across continents. The ultimate goal of our work is to better understand viral evolution and transmission so that we can prevent new outbreaks from occurring and mitigate the toll of endemic viral transmission. Although our lab primarily uses computational methods, we also generate new genomic data and draw on tools from basic virology to validate our computational findings.

Michael Letko
Paul G. Allen School for Global Health
Washington State University

Michael Letko

Assistant Professor
Paul G. Allen School for Global Health
Washington State University

Lab website: Laboratory of Functional Viromics

“Looking for preemergent threats with functional viromics”

Dr. Michael Letko is a molecular virologist studying the mechanisms underlying viral zoonosis. Dr. Letko received his PhD. from the Icahn School of Medicine at Mount Sinai in New York where he completed his thesis on viral-host co-evolution in lentiviruses and restriction factors. During his post-doctoral fellowship at the NIH’s Rocky Mountain Laboratory campus in Montana, Dr. Letko gained an appreciation for bat-borne emerging infectious diseases and focused his research primarily on coronaviruses. Today, Dr. Letko’s laboratory of functional viromics combines synthetic biology and molecular engineering to assess if and how uncharacterized viruses from the ever-growing virome can infect human cells. His lab is building new tools to explore and study a range of emerging viruses from orthohantavirus to coronavirus across a wide breadth of host reservoir species and in vitro model systems.